Adverse events58

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 58

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Neutrophil Count Decreased	Investigations	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	0	23
other	Neutrophil Count Decreased	Investigations	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	2	23
other	Platelet Count Decreased	Investigations	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	0	23
other	Platelet Count Decreased	Investigations	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	3	23
other	Anorexia	Metabolism and nutrition disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	2	23
other	Anorexia	Metabolism and nutrition disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	3	23
other	Hypocalcemia	Metabolism and nutrition disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	1	23
other	Hypocalcemia	Metabolism and nutrition disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	2	23
other	Arthralgia	Musculoskeletal and connective tissue disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	2	23
other	Arthralgia	Musculoskeletal and connective tissue disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	1	23
other	Dysgeusia	Nervous system disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	0	23
other	Dysgeusia	Nervous system disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	3	23
other	Headache	Nervous system disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	3	23
other	Headache	Nervous system disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	1	23
other	Depression	Psychiatric disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	0	23
other	Depression	Psychiatric disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	2	23
other	Insomnia	Psychiatric disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	1	23
other	Insomnia	Psychiatric disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	2	23
other	Urinary Incontinence	Renal and urinary disorders	Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA	2	23
other	Urinary Incontinence	Renal and urinary disorders	Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat	0	23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03018249/events?page=2

API reference For AI assistants